A Prospective Trial of Virtual Home Rehabilitation After Burn Injury

Sponsor
University of Washington (Other)
Overall Status
Recruiting
CT.gov ID
NCT03475654
Collaborator
(none)
50
1
2
55.7
0.9

Study Details

Study Description

Brief Summary

The overarching goal for this prospective randomized controlled trial (PRCT) is to determine whether a virtual-environment, home-rehabilitation program improves functional outcomes for individuals after a burn injury. Specifically, this study will test the efficacy of a technology-assisted rehabilitation program against current standard of home therapy.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Technology-assisted rehabilitation
  • Behavioral: Usual care
N/A

Detailed Description

This is a prospective, randomized controlled trial (PRCT) involving 50 adult burn survivors. This study tests the efficacy of a technology-assisted rehabilitation program against current standard of home therapy. There are two study groups for which subjects will be randomized: control and experimental.The control group will receive treatment as usual, which includes a personalized home exercise program prescribed by a burn therapist, prior to hospital discharge. The experimental group receives treatment as usual, in addition to training and use of the Jintronix platform for 3 months after hospital discharge. Participants will undergo their prescribed therapy regimen for 3 months, with outcomes follow-up to 12 months post-discharge.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
prospective randomized controlled trialprospective randomized controlled trial
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Virtual-Environment Home Rehabilitation: a Randomized Controlled Trial
Actual Study Start Date :
Feb 8, 2018
Anticipated Primary Completion Date :
Sep 30, 2021
Anticipated Study Completion Date :
Sep 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: technology-assisted rehabilitation

The experimental group will receive treatment as usual, in addition to training with the Jintronix platform. Participants will undergo their prescribed therapy regimen for 3 months, with outcomes follow-up to 12 months post-discharge.

Behavioral: Technology-assisted rehabilitation
The Jintronix software platform, coupled with the Microsoft Kinect for movement capture, contains individualized exercise modules to increase ROM, endurance and strength. Within this PRCT, online monitoring of activity and actigraphy measurements through a wearable device and completion of an online diary will provide enhanced monitoring of home activities.

Active Comparator: Usual care

The control group will receive treatment as usual, which includes a personalized home exercise program prescribed by a burn therapist, prior to hospital discharge. Participants will undergo their prescribed therapy regimen for 3 months, with outcomes follow-up to 12 months post-discharge.

Behavioral: Usual care
The control group will receive treatment as usual, which includes a personalized home exercise program prescribed by a burn therapist, prior to hospital discharge.

Outcome Measures

Primary Outcome Measures

  1. Level of physical activity [3 months after study enrollment]

    level of activity among enrolled subjects by actigraphy

Secondary Outcome Measures

  1. Range of motion (ROM) [Study enrollment, 3, 6 and 12 months after enrollment]

    ROM by subjects in each group

  2. Patient-reported outcome measures (PROMIS): sleep [Study enrollment, 3, 6, 12 months after enrollment]

    Sleep and sleep disturbance Short Form (SF)8B PROMIS tool

  3. Patient-reported outcome measures (PROMIS): social participation [Study enrollment, 3, 6, 12 months after enrollment]

    Participation in social roles and activities PROMIS tool SF6A

  4. Patient-reported outcome measures (PROMIS): pain interference [Study enrollment, 3, 6, 12 months after enrollment]

    Pain interference PROMIS tool SF6A

  5. Patient-reported outcome measures (PROMIS): fatigue [Study enrollment, 3, 6, 12 months after enrollment]

    Fatigue PROMIS tool SF6A

  6. Patient-reported outcome measures (PROMIS): stiffness [Study enrollment, 3, 6, 12 months after enrollment]

    Stiffness impact Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-ME) V2.0

  7. Patient-reported outcome measures (PROMIS): mobility [Study enrollment, 3, 6, 12 months after enrollment]

    Mobility PROMIS tool

  8. Patient-reported outcome measures (PROMIS): upper extremity [Study enrollment, 3, 6, 12 months after enrollment]

    Upper extremity PROMIS SF7A

  9. Return to work/school [up to 1 year]

    Date when subject returns to work or school

  10. Patient reported level of activity difficulty [Weekly beginning 1 week after study enrollment and concluding 3 months after study enrollment]

    Using 1-5 difficulty scale (1=no difficulty and 5=very difficult), subject is asked how difficult his/her activity has been for the past 2 days

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age greater than or equal to 18 years old (no upper age limit)

  • Ability to provide written, informed consent for study participation

  • Ability to read and understand English

  • Anticipated discharge to home environment

  • Home environment includes access to:

  • television (larger than 20 inches in diameter with High Definition Multimedia Interface input (HDMI)

  • internet and email address

  • telephone (cell phone or landline)

Exclusion Criteria:
  • Age less than 18 years

  • Inability to provide written, informed consent for study participation

  • Inability to read or understand English

  • Delirium (as determined by the Delirium Observation Score test)

  • Near-fall event at time of screening

  • Pregnant women

  • Discharge to non-home environment (e.g., shelter, street, skilled nursing facility)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Harborview Medical Center Seattle Washington United States 98104

Sponsors and Collaborators

  • University of Washington

Investigators

  • Principal Investigator: Tam Pham, MD, University of Washington

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tam Pham, Professor, School of Medicine: Surgery: Trauma, Burn and Critical Care Division, University of Washington
ClinicalTrials.gov Identifier:
NCT03475654
Other Study ID Numbers:
  • STUDY00003707
First Posted:
Mar 23, 2018
Last Update Posted:
Nov 9, 2020
Last Verified:
Nov 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tam Pham, Professor, School of Medicine: Surgery: Trauma, Burn and Critical Care Division, University of Washington
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 9, 2020